Browsing by Author "b4059f17-3e1d-442a-8cde-6d6e204be9bc"
Now showing items 1-3 of 3
-
Saavedra Ávila, Noemí Alejandra; Keshipeddy, Santosh; Guberman-Pfeffer, Matthew J.; Pérez Gallegos, Ayax; Saini, Neeraj; Schafer, Carolina; Carreño, Leandro J.; Gascón, José A.; Porcelli, Steven A.; Howell, Amy R. (American Chemical Society, 2020)Activation of invariant natural killer T (iNKT) cells by α-galactosylceramides (α-GalCers) stimulates strong immune responses and potent anti-tumor immunity. Numerous modifications of the glycolipid structure have been ...
-
Chennamadhavuni, Divya; Saavedra-Avila, Noemi Alejandra; Carreño Marquez, Leandro J.; Guberman-Pfeffer, Matthew J.; Arora, Pooja; Yongqing, Tan; Koay, Hui-Fern); Godfrey, Dale I.; Keshipeddy, Santosh; Richardson, Stewart K.; Sundararaj, Srinivasan; Lo, Jae Ho; Wen, Xiangshu; Gascón, José A.; Yuan, Weiming; Rossjohn, Jamie; Le Nours, Jéroˆme; Porcelli, Steven A.; Howell, Amy R. (Cell press, 2018-05-17)Glycosylceramides that activate CD1d-restricted invariant natural killer T (iNKT) cells have potential therapeutic applications for augmenting immune responses against cancer and infections. Previous studies using mouse ...
-
Chennamadhavuni, Divya; Saavedra-Avila, Noemi Alejandra; Carreño, Leandro J.; Guberman-Pfeffer, Matthew J.; Arora, Pooja; Yongqing, Tang; Koay, Hui Fern; Godfrey, Dale I.; Keshipeddy, Santosh; Richardson, Stewart K.; Sundararaj, Srinivasan; Lo, Jae Ho; Wen, Xiangshu; (Elsevier Ltd, 2018)© 2018 Elsevier Ltd Glycosylceramides that activate CD1d-restricted invariant natural killer T (iNKT) cells have potential therapeutic applications for augmenting immune responses against cancer and infections. Previous ...